Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial” - Sung Hwan Lee; Sun Young Yim; Ji Hoon Kim; Sunyoung S Lee; Ahmed O Kaseb; Peng Wei; Ju-Seog Lee (Clinical and Molecular Hepatology)